ClinicalTrials.govpublic full text
Proteomic and Inflammatory Omics Changes With Colchicine Therapy in Coronary Heart Disease
coronary heart disease (chd), colchicine, proteomics, biomarkers, olink, anti-inflammatory therapy, randomized controlled trial (rct), high-throughput screening, precision medicine, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1029751
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.